vs
Cooper Companies (The)（COO）与Rithm Capital Corp.（RITM）财务数据对比。点击上方公司名可切换其他公司
Cooper Companies (The)的季度营收约是Rithm Capital Corp.的1.3倍（$1.1B vs $828.2M），Rithm Capital Corp.净利率更高（13.2% vs 7.9%，领先5.3%），Rithm Capital Corp.同比增速更快（508.5% vs 4.6%），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs -17.9%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
Rithm Capital Corp.是总部位于美国纽约的投资管理机构，核心业务聚焦房地产投资与另类资产投资，依托专业的投研团队和成熟的市场运营经验，为合作伙伴及投资者提供优质的资产配置解决方案与长期收益回报。
COO vs RITM — 直观对比
营收规模更大
COO
是对方的1.3倍
$828.2M
营收增速更快
RITM
高出503.9%
4.6%
净利率更高
RITM
高出5.3%
7.9%
两年增速更快
COO
近两年复合增速
-17.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $828.2M |
| 净利润 | $84.6M | $109.5M |
| 毛利率 | 61.1% | — |
| 营业利润率 | 13.2% | 29.9% |
| 净利率 | 7.9% | 13.2% |
| 营收同比 | 4.6% | 508.5% |
| 净利润同比 | -28.0% | 27.7% |
| 每股收益（稀释后） | $0.42 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COORITM
| Q1 26 | — | $828.2M | ||
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $964.7M | $768.4M | ||
| Q4 24 | $1.0B | $2.1B | ||
| Q3 24 | $1.0B | $619.5M | ||
| Q2 24 | $942.6M | $1.2B |
净利润COORITM
| Q1 26 | — | $109.5M | ||
| Q4 25 | $84.6M | $85.0M | ||
| Q3 25 | $98.3M | $221.5M | ||
| Q2 25 | $87.7M | $311.7M | ||
| Q1 25 | $104.3M | $78.8M | ||
| Q4 24 | $117.5M | $290.2M | ||
| Q3 24 | $104.7M | $121.7M | ||
| Q2 24 | $88.9M | $235.6M |
毛利率COORITM
| Q1 26 | — | — | ||
| Q4 25 | 61.1% | — | ||
| Q3 25 | 65.3% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 68.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 66.1% | — | ||
| Q2 24 | 67.0% | — |
营业利润率COORITM
| Q1 26 | — | 29.9% | ||
| Q4 25 | 13.2% | 13.8% | ||
| Q3 25 | 16.6% | 21.4% | ||
| Q2 25 | 18.4% | 25.2% | ||
| Q1 25 | 18.9% | 7.4% | ||
| Q4 24 | 19.5% | 23.8% | ||
| Q3 24 | 19.2% | 7.3% | ||
| Q2 24 | 17.2% | 23.6% |
净利率COORITM
| Q1 26 | — | 13.2% | ||
| Q4 25 | 7.9% | 5.7% | ||
| Q3 25 | 9.3% | 20.0% | ||
| Q2 25 | 8.7% | 25.6% | ||
| Q1 25 | 10.8% | 10.3% | ||
| Q4 24 | 11.5% | 14.0% | ||
| Q3 24 | 10.4% | 19.7% | ||
| Q2 24 | 9.4% | 19.2% |
每股收益（稀释后）COORITM
| Q1 26 | — | $0.12 | ||
| Q4 25 | $0.42 | $0.09 | ||
| Q3 25 | $0.49 | $0.35 | ||
| Q2 25 | $0.44 | $0.53 | ||
| Q1 25 | $0.52 | $0.07 | ||
| Q4 24 | $0.59 | $0.50 | ||
| Q3 24 | $0.52 | $0.20 | ||
| Q2 24 | $0.44 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | — |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $8.2B | $9.1B |
| 总资产 | $12.4B | $53.4B |
| 负债/权益比越低杠杆越低 | 0.30× | — |
8季度趋势，按日历期对齐
现金及短期投资COORITM
| Q1 26 | — | — | ||
| Q4 25 | $110.6M | $1.8B | ||
| Q3 25 | $124.9M | $1.6B | ||
| Q2 25 | $116.2M | $1.6B | ||
| Q1 25 | $100.9M | $1.5B | ||
| Q4 24 | $107.6M | $1.5B | ||
| Q3 24 | $109.7M | $1.6B | ||
| Q2 24 | $112.4M | $1.2B |
总债务COORITM
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | $35.4B | ||
| Q3 25 | $2.4B | $32.2B | ||
| Q2 25 | $2.5B | $31.2B | ||
| Q1 25 | $2.5B | $32.2B | ||
| Q4 24 | $2.6B | $32.6B | ||
| Q3 24 | $2.6B | $29.6B | ||
| Q2 24 | $2.7B | $30.1B |
股东权益COORITM
| Q1 26 | — | $9.1B | ||
| Q4 25 | $8.2B | $8.4B | ||
| Q3 25 | $8.4B | $8.5B | ||
| Q2 25 | $8.3B | $7.9B | ||
| Q1 25 | $8.1B | $7.8B | ||
| Q4 24 | $8.1B | $7.8B | ||
| Q3 24 | $7.9B | $7.7B | ||
| Q2 24 | $7.8B | $7.3B |
总资产COORITM
| Q1 26 | — | $53.4B | ||
| Q4 25 | $12.4B | $53.1B | ||
| Q3 25 | $12.4B | $47.2B | ||
| Q2 25 | $12.4B | $44.3B | ||
| Q1 25 | $12.2B | $45.3B | ||
| Q4 24 | $12.3B | $46.0B | ||
| Q3 24 | $12.1B | $42.3B | ||
| Q2 24 | $12.0B | $42.0B |
负债/权益比COORITM
| Q1 26 | — | — | ||
| Q4 25 | 0.30× | 4.20× | ||
| Q3 25 | 0.29× | 3.79× | ||
| Q2 25 | 0.30× | 3.92× | ||
| Q1 25 | 0.31× | 4.14× | ||
| Q4 24 | 0.32× | 4.18× | ||
| Q3 24 | 0.33× | 3.87× | ||
| Q2 24 | 0.34× | 4.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | — |
| 自由现金流经营现金流 - 资本支出 | $149.9M | — |
| 自由现金流率自由现金流/营收 | 14.1% | — |
| 资本支出强度资本支出/营收 | 9.2% | — |
| 现金转化率经营现金流/净利润 | 2.93× | — |
| 过去12个月自由现金流最近4个季度 | $433.7M | — |
8季度趋势，按日历期对齐
经营现金流COORITM
| Q1 26 | — | — | ||
| Q4 25 | $247.9M | $-114.6M | ||
| Q3 25 | $261.4M | $-2.0B | ||
| Q2 25 | $96.2M | $-557.1M | ||
| Q1 25 | $190.6M | $1.4B | ||
| Q4 24 | $268.1M | $-1.8B | ||
| Q3 24 | $207.5M | $768.1M | ||
| Q2 24 | $111.0M | $-55.7M |
自由现金流COORITM
| Q1 26 | — | — | ||
| Q4 25 | $149.9M | — | ||
| Q3 25 | $164.5M | — | ||
| Q2 25 | $18.1M | — | ||
| Q1 25 | $101.2M | — | ||
| Q4 24 | $128.1M | — | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $36.9M | — |
自由现金流率COORITM
| Q1 26 | — | — | ||
| Q4 25 | 14.1% | — | ||
| Q3 25 | 15.5% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 12.6% | — | ||
| Q3 24 | 11.8% | — | ||
| Q2 24 | 3.9% | — |
资本支出强度COORITM
| Q1 26 | — | — | ||
| Q4 25 | 9.2% | — | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 13.7% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 7.9% | — |
现金转化率COORITM
| Q1 26 | — | — | ||
| Q4 25 | 2.93× | -1.35× | ||
| Q3 25 | 2.66× | -9.22× | ||
| Q2 25 | 1.10× | -1.79× | ||
| Q1 25 | 1.83× | 18.03× | ||
| Q4 24 | 2.28× | -6.04× | ||
| Q3 24 | 1.98× | 6.31× | ||
| Q2 24 | 1.25× | -0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
RITM
| Servicing revenue, net | $375.1M | 45% |
| Other | $234.9M | 28% |
| Gain on originated residential mortgage loans, held-for-sale, net | $195.0M | 24% |
| Other revenue | $23.3M | 3% |
